Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.20
-0.85 (-2.57%)
Mar 24, 2026, 1:26 PM CST
Market Cap2.35B -35.5%
Revenue (ttm)n/a
Net Income-141.91M
EPS-1.99
Shares Out71.32M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,220
Average Volume37,813
Open33.05
Previous Close33.05
Day's Range32.05 - 33.05
52-Week Range32.05 - 56.50
Beta-0.20
RSI35.23
Earnings DateMar 13, 2026

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase IIa clinical trial and SNP-630 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan. It is also developing SNP-810 is in phase II clinical trial for use in pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for ac... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 48
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements